We are live on ! Find out more
SCM

Scopia Capital Management Portfolio holdings

AUM $112M
1-Year Est. Return 48.41%
This Fund
S&P 500
This Quarter Est. Return
+5.69%
1 Year Est. Return
+48.41%
3 Year Est. Return
+58.7%
5 Year Est. Return
+80.15%
10 Year Est. Return
+533.22%
AUM
$5.41B
AUM Growth
+$136M
Cap. Flow
-$609M
Cap. Flow %
-11.24%
Top 10 Hldgs %
65%
Holding
45
New
7
Increased
9
Reduced
10
Closed
13

Top Buys

Rank Stock Value
1
FNF icon
Fidelity National Financial
FNF
+$118M
2
TRGP icon
Targa Resources
TRGP
+$85.3M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$67.8M
4
CNDT icon
Conduent
CNDT
+$45.1M
5
JD icon
JD.com
JD
+$44.5M

Top Sells

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$189M
2
UTHR icon
United Therapeutics
UTHR
+$133M
3
SIG icon
Signet Jewelers
SIG
+$119M
4
EWJ icon
iShares MSCI Japan ETF
EWJ
+$105M
5
SPR
Spirit AeroSystems
SPR
+$88.2M

Sector Composition

Rank Sector Weight
1 Healthcare 27.5%
2 Industrials 13.96%
3 Communication Services 12.79%
4 Miscellaneous 12.72%
5 Real Estate 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCE.A
1
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$516M 9.52%
23,670,271
+615,538
+3% +$13.6M
SPR
2
DELISTED
Spirit AeroSystems
SPR
$383M 7.07%
6,605,292
-1,507,017
-19% -$88.2M
NFLX icon
3
Netflix
NFLX
$325B
$378M 6.98%
25,554,380
-829,810
-3% -$11.6M
SPY icon
4
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$799B
$358M 6.6%
+1,516,800
New +$352M
JD icon
5
JD.com
JD
$36.7B
$332M 6.13%
10,666,609
+1,511,418
+17% +$44.5M
IWM icon
6
PUT
iShares Russell 2000 ETF
IWM
$76.8B
$331M 6.12%
2,410,600
+1,660,000
+221% +$227M
UTHR icon
7
United Therapeutics
UTHR
$21.5B
$321M 5.93%
2,373,187
-875,682
-27% -$133M
JCI icon
8
Johnson Controls International
JCI
$83.9B
$318M 5.88%
7,556,517
-275,866
-4% -$11.7M
BIDU icon
9
Baidu
BIDU
$30.9B
$306M 5.66%
1,776,207
-441,073
-20% -$77.6M
ITRI icon
10
Itron
ITRI
$4.01B
$277M 5.11%
4,558,387
– –
GWPH
11
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$240M 4.44%
1,988,317
-96,250
-5% -$11.8M
TMH
12
DELISTED
Team Health Holdings Inc
TMH
$145M 2.68%
3,338,649
– –
HZNP
13
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$143M 2.64%
9,686,262
+1,604,612
+20% +$26M
WMB icon
14
Williams Companies
WMB
$87.3B
$141M 2.6%
4,763,883
-354,402
-7% -$10.2M
FNF icon
15
Fidelity National Financial
FNF
$11.7B
$125M 2.32%
+4,640,130
New +$118M
CNMD icon
16
CONMED
CNMD
$1.4B
$123M 2.28%
2,774,045
– –
LGND icon
17
Ligand Pharmaceuticals
LGND
$5.45B
$123M 2.28%
1,865,623
+1,031,345
+124% +$67.8M
ACOR
18
DELISTED
Acorda Therapeutics
ACOR
$117M 2.16%
46,403
+8,636
+23% +$24.9M
NDRM
19
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$116M 2.15%
4,383,358
– –
TVTX icon
20
Travere Therapeutics
TVTX
$5.89B
$109M 2.01%
5,883,656
+794,022
+16% +$15.5M
CNX icon
21
CNX Resources
CNX
$5.26B
$92M 1.7%
6,578,900
+1,279,281
+24% +$18M
TRGP icon
22
Targa Resources
TRGP
$61.6B
$88M 1.62%
+1,468,325
New +$85.3M
SWX icon
23
Southwest Gas
SWX
$6.26B
$82.7M 1.53%
997,996
-274,672
-22% -$22.4M
AR icon
24
Antero Resources
AR
$12B
$77.4M 1.43%
3,393,083
+222,345
+7% +$5.44M
DY icon
25
Dycom Industries
DY
$8.54B
$55M 1.02%
591,701
– –
1
2

Similar funds

SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
TFS
truNorth Financial Services Chambersburg, Pennsylvania $112M AUM
WAM
Watershed Asset Management San Francisco, California $112M AUM
CS
Crescent Sterling Metairie, Louisiana $112M AUM 26.76% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $112M AUM 3.02% 1-Year Est. Return
TBFA
Three Bearings Fiduciary Advisors Hampton, New Hampshire $112M AUM
VDC
Van Diest Capital Poly City, Iowa $112M AUM
RQS
Ramsey Quantitative Systems Louisville, Kentucky $112M AUM 16.38% 1-Year Est. Return

Scopia Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Scopia Capital Management held 45 positions worth $5.41B, up 2.6% from $5.28B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Scopia Capital Management withdrew a net $609M in Q1 2017, closing 13 positions and reducing 10 holdings. Its most notable exit was Zebra Technologies, an estimated $189M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Scopia Capital Management opened a new position in Fidelity National Financial worth $125M.

  • Scopia Capital Management's largest Q1 2017 buy was Fidelity National Financial: 4,640,130 shares worth $125M.
  • Scopia Capital Management added most to Ligand Pharmaceuticals in Q1 2017, an estimated $67.8M increase.
  • Scopia Capital Management's biggest Q1 2017 reduction was United Therapeutics, cutting an estimated $133M.
  • Scopia Capital Management fully exited Zebra Technologies in Q1 2017, selling an estimated $189M.
  • Scopia Capital Management's ten largest holdings make up 65% of its $5.41B portfolio in Q1 2017.
  • Scopia Capital Management opened 7 new positions and closed 13 in Q1 2017.
  • Scopia Capital Management's portfolio value rose 2.6% quarter-over-quarter to $5.41B.

Based on Scopia Capital Management's 13F filing for Q1 2017, filed 15 May 2017.